Monthly Archives: February 2017

Despite extensive investigations demonstrating that immune responses are induced by many experimental DNA vaccines and that their character and magnitude can be readily manipulated, many of the processes noted above, related to DNA vaccines are still a “black box” with … Continue reading →

21 To study the release kinetics in-vitro release data was applied to kinetic models such as zero-order, first order, Higuchi and Korsmeyer–Peppas. 22 The formulated beads in optimized formulation were sealed in vials and kept for 90 days at 40 °C/75% … Continue reading →

Le diagnostic repose sur la détection de cette population lymphocytaire au sein des organes atteints. Une parotidomégalie s’observe dans 88 % des cas avec ou sans syndrome sec qui reste toutefois rare. L’atteinte pulmonaire se caractérise par une infiltration interstitielle lymphocytaire … Continue reading →

For example, of the 105 participants, only 27 (26%) had positive provocative tests and arthroscopies for SL ligament injuries, 35 (33%) had positive provocative tests and arthroscopies for TFCC injuries, 17 (17%) had positive provocative tests and arthroscopies for lunate … Continue reading →

Intake of acetaminophen like drugs and certain chemicals may also lead to hepatocellular carcinoma. N-nitrosodiethylamine (NDEA) is a potent carcinogenic dialkyl nitrosoamine present in tobacco smoke, water, cheddar cheese, cured and fried meals and in a number of alcoholic beverages. … Continue reading →

’ Geoffrey Maitland was a giant; we mourn his passing, C59 in vitro but celebrate his life and contribution. ““Neck pain affects up to two-thirds of people at some point during their life (Cote et al 1998). It remains one … Continue reading →

Compliance to Selleck DAPT vaccine intake was high for subsequent doses; only 3.5% of infants did not receive all the three intended doses. Vaccine efficacy in children up to 2 years of age was 55.1% (95% CI 39.9 to 66.4; … Continue reading →

Recent estimates have projected a total of over 40 country introductions of rotavirus vaccine by 2015; this figure is in addition to the five countries that introduced vaccine prior to 2012 [43] and [44]. Thus, for this analysis we have assumed that … Continue reading →

0–66.7%) and 29.9% (range across study period 0.0–53.1%) from Western part of India. The difference reported from the four regions is statistically significant having two-tailed P value of 0.0342 using the Chi-square test. No statistically significant differences were observed between … Continue reading →

In this case, SIVAC would provide support to the country to help them identify available data on disease burden, health Paclitaxel economics, and vaccine safety, as well as data on logistical and cold chain issues. SIVAC would also help in … Continue reading →